WCM Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.3M Sell
14,882
-430
-3% -$439K 0.03% 109
2026
Q1
$13.6M Sell
15,312
-624
-4% -$633K 0.03% 121
2025
Q4
$17.2M Sell
15,936
-427
-3% -$408K 0.04% 107
2025
Q3
$11.9M Sell
16,363
-630
-4% -$469K 0.02% 134
2025
Q2
$13.2M Buy
16,993
+38
+0.2% +$29.5K 0.03% 133
2025
Q1
$13.9M Buy
16,955
+250
+1% +$208K 0.04% 116
2024
Q4
$12.9M Buy
16,705
+3,445
+26% +$2.85M 0.03% 139
2024
Q3
$11.6M Buy
13,260
+1,716
+15% +$1.54M 0.03% 142
2024
Q2
$10.5M Buy
11,544
+67
+0.6% +$53.6K 0.02% 141
2024
Q1
$8.93M Buy
+11,477
New +$8.17M 0.02% 143

Other funds holding LLY

WCM Investment Management's LLY Position: Q2 2026 in Review

WCM Investment Management reduced its Eli Lilly (LLY) stake by 2.8% in Q2 2026, selling an estimated $439K and leaving 14,882 shares worth $18.3M. The position accounts for 0.03% of the portfolio, ranked #109.

WCM Investment Management first reported a position in LLY in Q1 2024 and has held it in 10 quarters since. 4,601 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • WCM Investment Management held 14,882 shares of Eli Lilly worth $18.3M as of Q2 2026.
  • WCM Investment Management sold 430 Eli Lilly shares in Q2 2026, an estimated $439K.
  • Eli Lilly made up 0.03% of WCM Investment Management's portfolio in Q2 2026, its #109 holding.
  • WCM Investment Management first reported a position in Eli Lilly in Q1 2024 and has held it in 10 quarters since.
  • 4,601 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on WCM Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.